Refusal of medical contraception in hypermodern age: does sexuality want to emancipate itself from science?

Over-the-Counter Access to Hormonal Contraception: ACOG Committee Opinion, Number 788. Obstet Gynecol. 2019 Oct;134(4):e96-e105. Available at: https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2019/10/over-the-counter-access-to-hormonal-contraception

Abrams LM, Look KA. Community pharmacists and improving contraception access: Relationships between contraceptive counseling and dispensing contraceptives. Res Social Adm Pharm. 2023;19(12):1602-1605.

Grindlay K, Key K, Bradford RD, Amato C, Blanchard K, Grossman D. Pilot label comprehension study for an over-the-counter combined oral contraceptive pill in the United States. Perspect Sex Reprod Health. 2023;55(1):28-37.

Grossman D, Fuentes L. Over-the-counter access to oral contraceptives as a reproductive healthcare strategy. Curr Opin Obstet Gynecol. 2013;25(6):500-505.

Food and Drug Administration. FDA Approves First Nonprescription Daily Oral Contraceptive. July 13, 2023. Available at : https://www.fda.gov/news-events/press-announcements/fda-approves-first-nonprescription-daily-oral-contraceptive

La contraception en France – Faits et chiffres. Statista. Available at: https://fr.statista.com/themes/2750/les-francais-et-la-contraception/#topicOverview

Aubet N. L’individu hypermoderne. Érès, « Sociologie clinique », 2006.

Vilain A. Le nombre des interruptions volontaires de grossesse augmente en 2022. Available at : https://drees.solidarites-sante.gouv.fr/publications-communique-de-presse/etudes-et-resultats/le-nombre-des-interruptions-volontaires-de#:~:text=En%202022%2C%20234%20300%20interruptions,(graphique%20ci%2Ddessous)

Roland N, Neumann A, Hoisnard L, Duranteau L, Froelich S, Zureik M, Weill A. Use of progestogens and the risk of intracranial meningioma: national case-control study. BMJ. 2024;384:e078078.

Piper JG, Follett KA, Fantin A. Sphenoid wing meningioma progression after placement of a subcutaneous progesterone agonist contraceptive implant. Neurosurgery. 1994;34(4):723-725.

Apra C, Roblot P, Alkhayri A, Le Guérinel C, Polivka M, Chauvet D. Female gender and exogenous progesterone exposition as risk factors for spheno-orbital meningiomas. J Neurooncol. 2020;149(1):95-101.

Expert reaction to study finding an association between prolonged use of progestogen hormones and brain tumour risk. Science Media Centre March 27, 2024. Available at: https://www.sciencemediacentre.org/expert-reaction-to-study-finding-an-association-between-prolonged-use-of-progestogen-hormones-and-brain-tumour-risk/#:~:text=%E2%80%9CThis%20large%20study%20using%20French,women%20using%20progestogens%20to%20panic

Infections sexuellement transmissibles. Santé publique France November 29, 2022. Available at: https://www.santepubliquefrance.fr/maladies-et-traumatismes/infections-sexuellement-transmissibles/chlamydiae

Contraception: la pilule provoque 2500 accidents et 20 décès par an en France. Le Parisien March 26, 2013. Available at: https://www.leparisien.fr/archives/la-pilule-provoque-2-500-accidents-et-20-deces-par-an-en-france-26-03-2013-2672163.php

Harrel E. Neuromarketing: What You Need to Know. Harvard Business Review. Published January 23, 2019. Available at: https://hbr.org/2019/01/neuromarketing-what-you-need-to-know

World Health Organization. Sexually transmitted infections (STIs) [fact sheet]. 2024. Available at : https://www.who.int/news-room/fact-sheets/detail/sexually-transmitted-infections-(stis)#:~:text=STIs%20have%20a%20profound%20impact,and%20trichomoniasis%20(156%20million)

Choucroun D. “Sexual recession” in the mainstream and scientific press: and yet sexually transmitted infections (stis) are on the rise. J Sex Med;2024;21(Suppl 4):qdae041.083.

Paquot T, Younes C. Espace et lieu dans la pensée occidentale. Ed. La Découverte. 2012.

Choucroun D. Refusal of medical contraception: false hormonophobia, true lack of pleasure, the doubt of digital contraception. J Sex Med;2023;20(Suppl 4):qdad062.166qdae041.083.

Andrejek N, Fetner T, Heath M. Climax as Work: Heteronormativity, Gender Labor, and the Gender Gap in Orgasms. Gend Soc. 2022;36(2):189-213.

Almazrouei B, Islayem D, Alskafi F, et al. Steroid hormones in wastewater: Sources, treatments, environmental risks, and regulations. Emerging Contaminants. 2023;9(2):100210. Available at: https://www.sciencedirect.com/science/article/pii/S2405665023000082

Niemeyer A. Establishment of analytical methods to assess endocrine disrupting compounds in a Swedish wastewater treatment plant. Published August 8, 2019. Available at: https://stud.epsilon.slu.se/14854/

du Plessis M, Fourie C, Stone W, Engelbrecht AM. The impact of endocrine disrupting compounds and carcinogens in wastewater: Implications for breast cancer. Biochimie. 2023;209:103-115.